You figure out the best path forward by meeting with agencies and preparing data. So the data should be significantly prepared, not starting from scratch.
Anavex didn't wait a year before making a decision to meet EMA, we recently learned they had several discussions with the EMA and if that governmental organization is anything like the pace of the FDA those meetings took several months.